Zhihan Chen

Zhihan Chen

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
ZCZhihan Chen
Zhihan Chen
YWYitong Wang
Yitong Wang
RWRui Wang
Rui Wang
JXJin Xie
Jin Xie
YRYulan Ren
Yulan Ren
Objectives. To assess the efficacy of acupuncture in treating opioid use disorder (OUD). Design. Systematic review and meta‐analysis. Methods. PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Embase, PsycINFO, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science, ProQuest Dissertation and Theses, Allied and Complementary Medicine Database (AMED), Clinicaltrials.gov, and who.int/trialsearch were searched from inception to 23 December 2017. The methodological quality of selected studies and the quality of evidence for outcomes were assessed, respectively, by the Cochrane risk of bias assessment tool and the GRADE approach. Statistical analyses were conducted by RevMan 5.3. Results. A total of nine studies involving 1063 participants fulfilled the inclusion criteria. The results showed that acupuncture could be more beneficial than no treatment/sham acupuncture in terms of changes in craving for opioid (MD ‐2.18, 95% CI ‐3.10 to ‐1.26), insomnia (MD 2.31, 95% CI 1.97 to 2.65), and depression (SMD ‐1.50, 95% CI ‐1.85 to ‐1.15). In addition, these findings showed that, compared to sham electroacupuncture (EA), EA had differences in alleviating symptoms of craving (SMD ‐0.50, 95% CI ‐0.94 to ‐0.05) and depression (SMD ‐1.07, 95% CI ‐1.88 to ‐0.25) and compared to sham transcutaneous acupoint electrical stimulation (TEAS), TEAS had differences in alleviating symptoms of insomnia (MD 2.31, 95% CI 1.97 to 2.65) and anxiety (MD ‐1.26, 95% CI ‐1.60 to ‐0.92) compared to no treatment/sham TEAS. Conclusions. Acupuncture could be effective in treating OUD. Moreover, EA could effectively alleviate symptoms of craving for opioid and depression, and TEAS could be beneficial in improving symptoms of insomnia and anxiety. Nevertheless, the conclusions were limited due to the low‐quality and small number of included studies. PROSPERO registration number is CRD42018085063.

6 July 2020 in Purinergic Signalling
Verified
Journal Article
Open access
PDF file
YRYulan Ren
Yulan Ren
ZCZhihan Chen
Zhihan Chen
RWRui Wang
Rui Wang
YYYang Yu
Yang Yu
DLDehua Li
Dehua Li
YHYonggang He
Yonggang He
Electroacupuncture (EA) can improve myocardial ischemia (MI) injury; nevertheless, the mechanism is not entirely clear. And there were disagreements about whether the effect of EA at acupoint in disease-affected meridian is better than EA at acupoint in non-affected meridian and sham acupoint. Here, we showed that the effect of EA at Neiguan (PC6) is better than EA at Hegu (LI4) and sham acupoint in affecting RPP and ECG, increasing ATP and ADO production, decreasing AMP production, and upregulating the mRNA expression levels of A1AR, A2aAR, and A2bAR; knockdown of A1AR or A2bAR reversed the effect of EA at PC6 in alleviating MI injury; knockdown of A2aAR had no influence on the cardiac protection of EA at PC6; thus, the cardioprotective effect of EA at PC6 needs A1AR and A2bAR, instead of A2aAR; considering that the cardio protection of adenosine receptor needs activation of other adenosine receptors, one of the reasons may be that after silence of A1AR or A2bAR, EA at PC6 could not impact the expression levels of the other two adenosine receptors, and after silence of A2aAR, EA at PC6 could impact the expression levels of A1AR and A2bAR. These results suggested that EA at PC6 may be a potential and effective treatment for MI by activation of A1AR and A2bAR.

24 November 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
YZYiwei Zeng
Yiwei Zeng
JXJialin Xia
Jialin Xia
ZCZhihan Chen
Zhihan Chen
XTXiaoping Tian
Xiaoping Tian
YRYulan Ren
Yulan Ren
Introduction Cancer-related fatigue (CRF) is a prevalent symptom in cancer survivors. Transcutaneous electrical acupoint stimulation (TEAS) has been reported as a promising therapy for CRF. This protocol is proposed for a systematic review that aims to assess the efficacy and safety of TEAS for CRF. Methods and analysis Cochrane Central Register of Controlled Trials, PubMed, Medline, Embase, Chinese National Knowledge Infrastructure, VIP, Wanfang database, Chinese Biomedical Literature Database, Chinese Clinical Trial Registry System, ClinicalTrials.gov and WHO International Clinical Trial Registry Platform will be searched from inception to 31 January 2021 without language limitations. The eligible randomised controlled trials will be included. The primary outcomes include changes in the revised Piper fatigue scale, the Brief fatigue inventory, the Multidimensional fatigue inventory and the Functional assessment of chronic illness therapy fatigue. The secondary outcomes are the quality-of-life measurement index, the Hamilton anxiety scale, the Hamilton depression scale and adverse events. The selection of studies, data extraction and assessment of risk of bias will be conducted independently by two reviewers. Data synthesis will be performed using RevMan V.5.4.1. The quality of evidence will be evaluated with the Grading of Recommendations, Assessment, Development and Evaluation system. This study will strictly adhere to the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines. Ethics and dissemination Ethical approval is not required as this is a systematic review and meta-analysis based on previously published studies involving no private information of patients. The results of this study will be disseminated in a peer-reviewed journal. PROSPERO registration number CRD42020220282.

21 June 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
ZCZhihan Chen
Zhihan Chen
RWRui Wang
Rui Wang
MZMin Zhang
Min Zhang
YWYitong Wang
Yitong Wang
YRYulan Ren
Yulan Ren
Introduction Opioid use disorder (OUD) is a worldwide health problem. Clinical trials indicated that acupuncture combined with medication is effective in OUD, however, there are different conclusions presented by previous trials. This study is designed to evaluate the efficacy and safety of acupuncture combined with medication in OUD. Methods and analysis PubMed, CENTRAL, Embase, Web of Science, CINAHL, PsycINFO, ProQuest Dissertation and Theses, AMED, OpenGrey, Clinicaltrials.gov and who.int/trialsearch will be searched in September 2019 without a language restriction. Randomised controlled trials (RCTs) and quasi-RCTs which included participants with OUD receiving acupuncture therapy combined with medication versus control group will be included in this study. Two reviewers will independently screen studies, extract data, assess risk of bias by the Cochrane risk of bias assessment tool and assess quality of evidence by Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach. Any disagreements will be arbitrated by the third reviewer. Data synthesis and analysis will be conducted by using RevMan V.5.3. Subgroup analyses, sensitivity analysis, meta-regression and reporting bias assessment will be conducted if necessary and appropriate. Ethics and dissemination On account of the nature of this systematic review and meta-analysis, ethical approval is not required. The results will be published in a peer-reviewed journal. PROSPERO registration number CRD42019123436.

1 March 2021 in Annals of Palliative Medicine
Verified
Journal Article
Open access
PDF file
SZShengli Zhang
Shengli Zhang
ZCZhihan Chen
Zhihan Chen
YWYanfang Wu
Yanfang Wu
DLDiantian Lin
Diantian Lin
JHJuanjuan He
Juanjuan He
HLHe Lin
He Lin
Efficacy and safety of thalidomide on psychological symptoms and sleep disturbances in the patient with refractory ankylosing spondylitis Shengli Zhang, Zhihan Chen, Yanfang Wu, Diantian Lin, Juanjuan He, Jianwen Liu, Fei Gao, He Lin

26 May 2025 in Phytomedicine
Verified
Journal Article
Closed access
ZCZhihan Chen
Zhihan Chen
LZLingyuan Zhong
Lingyuan Zhong
MLMengsong Liu
Mengsong Liu
PDPeiwen Ding
Peiwen Ding
NJNan Jia
Nan Jia
JTJianyuan Tang
Jianyuan Tang